BioRestorative Therapies VP R&D Resigns, Claims $1.29M Severance

What Happened

• BioRestorative Therapies, Inc. (BRTX) filed an 8-K on Sept. 11, 2026 disclosing that on Sept. 4, 2026 Mr. Silva submitted a resignation from his employment and his role as Vice President of Research and Development. He asserts the resignation is for "Good Reason" under an Employment Agreement dated June 10, 2026 (purportedly amended July 2026) and claims this was triggered by a "Change in Control" tied to June 2026 Board changes related to a Revolving Loan Agreement with Bowery Group LLC.
• Mr. Silva demands severance and other benefits under the Employment Agreement, including approximately $1.29 million in cash severance, acceleration of outstanding equity awards, and continuation of certain benefits. The Board has acknowledged the resignation for corporate records but disputes the validity of the Employment Agreement and the "Good Reason"/Change in Control assertions.

Key Details

• Resignation notice dated: September 4, 2026; 8-K filed: September 11, 2026.
• Claimed cash severance: approximately $1.29 million; plus alleged acceleration of equity awards and benefit continuation.
• Employment Agreement referenced: dated June 10, 2026, purportedly amended in July 2026; Loan Agreement with Bowery Group LLC dated June 10, 2026 cited as basis for alleged Change in Control.
• Board has authorized a special-counsel investigation into the negotiation and approval of the Employment Agreement (and related agreements for former CEO and CFO) and has stated no payments will be made under the Employment Agreement pending the investigation, except accrued/unpaid base salary and amounts required by wage law.

Why It Matters

• Potential cash and equity impact: if the Employment Agreement is ultimately found valid and the resignation qualifies as "Good Reason," the company could face a near-term cash payout (~$1.29M) and acceleration of equity awards, which could affect cash position and equity overhang.
• Governance signal: the Board’s special-counsel investigation into how the employment agreements were handled is a material governance event that investors should monitor for outcomes and any resulting board or management actions.
• Uncertainty remains: the Board disputes the claims and has reserved its rights, and the company has paused payments pending the investigation — so payment and corporate consequences are currently unresolved.